Market revenue in 2023 | USD 67.7 million |
Market revenue in 2030 | USD 100.2 million |
Growth rate | 5.7% (CAGR from 2023 to 2030) |
Largest segment | Finished drug formulation |
Fastest growing segment | API |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Medical Device, API, Finished Drug Formulation |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to chemistry, manufacturing, and control (cmc) services outsourcing market will help companies and investors design strategic landscapes.
Finished drug formulation was the largest segment with a revenue share of 41.95% in 2023. Horizon Databook has segmented the Norway chemistry, manufacturing, and control (cmc) services outsourcing market based on medical device, api, finished drug formulation covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway chemistry, manufacturing, and control (cmc) services outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into Norway chemistry, manufacturing, and control (cmc) services outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account